|
|
|
GMRE Dividend History & Description — Global Medical REIT Inc
Global Medical REIT is an internally managed real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Co. conducts its business through an umbrella partnership REIT structure in which its properties are owned by wholly owned subsidiaries of its operating partnership, Global Medical REIT L.P. (the Operating Partnership). Co.'s wholly owned subsidiary, Global Medical REIT GP LLC, is the sole general partner of its Operating Partnership. Co.'s portfolio consists of medical office building, inpatient rehab facility, surgical hospital, and other. Preferred: GMRE.PRA When considering the Global Medical REIT Inc stock dividend history, we have taken known splits into account, such that the GMRE dividend history is presented on a split-adjusted ("apples to apples") basis. Global Medical REIT Inc dividend history is presented both in graphical/chart form, and as a GMRE dividend history data table along the right-hand column.
Name: |
Global Medical REIT Inc |
Website: |
www.globalmedicalreit.com |
Sector: |
REITs |
Number of ETFs Holding GMRE: |
26 (see which ones) |
Total Market Value Held by ETFs: |
$68,851,747.45 |
Total Market Capitalization: |
$532,000,000 |
% of Market Cap. Held by ETFs: |
12.94% |
|
GMRE Stock Dividend HistoryThe GMRE dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable GMRE historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the GMRE dividend history record. Also see the GMRE stock dividend history data table along the right-hand column below.
|
|
|
|
Buy (2.71 out of 4)
20th percentile
|
PARTNER NEWS:Thu, Feb 22, 6:25 AM, Zacks
City Office REIT (CIO) Q4 FFO Meet Estimates City Office REIT (CIO) delivered FFO and revenue surprises of 0% and 0.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
|
|